Free Newsletter
Gene therapy study relieves pain in RA mice model
Scientists have successfully tested a new gene therapy approach to treating pain and other symptoms linked to rheumatoid arthritis. They took an adeno-associated virus--a standard delivery tool in gene therapy--to transport the mu-opioid receptor gene to the joints of afflicted mice. Those receptors facilitate the entry of the body's natural painkillers into cells and the more of them a patient has around affected joints the more responsive they are to the natural approach. Dr. Stephanos Kyrkanides of the University of Rochester Medical Center in New York said that the method eased the pain in the mice and also treated the pathology. The researchers used the actual human gene in the study, leading them to believe that there is a high likelihood of success when the same approach is tried on humans.
- read the report on the gene therapy work from Scientific American
ALSO: Another research team has used gene therapy to cure hereditary blindness caused by a genetic impairment. Report
Related Article:
Scientists unveil new pathway for rheumatoid arthritis. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact




